Cargando…
Anticoagulant-related nephropathy: systematic review and meta-analysis
BACKGROUND: The aim of this study was to report the prevalence and mortality associated with anticoagulant-related nephropathy (ARN) through a systematic review of the literature. METHODS: Electronic searches were conducted in the Medline and EMBASE databases, and manual searches were performed in t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543958/ https://www.ncbi.nlm.nih.gov/pubmed/31198540 http://dx.doi.org/10.1093/ckj/sfy133 |
_version_ | 1783423173076713472 |
---|---|
author | de Aquino Moura, Karolinny Borinelli Behrens, Paula Marques Prates Pirolli, Rafaela Sauer, Aimee Melamed, Dayana Veronese, Francisco Veríssimo da Silva, André Luis Ferreira Azeredo |
author_facet | de Aquino Moura, Karolinny Borinelli Behrens, Paula Marques Prates Pirolli, Rafaela Sauer, Aimee Melamed, Dayana Veronese, Francisco Veríssimo da Silva, André Luis Ferreira Azeredo |
author_sort | de Aquino Moura, Karolinny Borinelli |
collection | PubMed |
description | BACKGROUND: The aim of this study was to report the prevalence and mortality associated with anticoagulant-related nephropathy (ARN) through a systematic review of the literature. METHODS: Electronic searches were conducted in the Medline and EMBASE databases, and manual searches were performed in the reference lists of the identified studies. The studies were selected by two independent researchers, first by evaluating the titles and abstracts and then by reading the complete texts of the identified studies. Case series, cross-sectional studies, cohort studies and case–control studies reporting the prevalence and factors associated with ARN were selected. The methodological quality was assessed using the Newcastle–Ottawa scale. Meta-analyses of the prevalence of ARN and 5-year mortality using the random effects model were performed when possible. Heterogeneity was assessed using the I(2) statistic. RESULTS: Five studies were included. Prevalence of ARN ranged from 19% to 63% among the four included cohort studies. Meta-analysis of these resulted in high heterogeneity [I(2) 96%, summary effect 31%; 95% confidence interval (CI) 22–42%]. Subgroup meta-analysis yielded an ARN prevalence of 20% among studies that included patients with fewer comorbidities (I(2) 12%; 95% CI 19–22%). In a direct comparison, meta-analysis of the 5-year mortality rate between anticoagulated patients who had experienced ARN and anticoagulated patients without ARN, patients with ARN were 91% more likely to die (risk ratio = 1.91; 95% CI 1.22–3; I(2) 87%). Risk factors for ARN that were reported in the literature included initial excessive anticoagulation, chronic kidney disease, age, diabetes, hypertension, cardiovascular disease and heart failure. CONCLUSIONS: ARN studies are scarce and heterogeneous, and present significant methodological limitations. The high prevalence of ARN reported herein suggests that this entity is underdiagnosed in clinical practice. Mortality in patients with ARN seems to be high compared with patients without this condition in observational studies. |
format | Online Article Text |
id | pubmed-6543958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-65439582019-06-13 Anticoagulant-related nephropathy: systematic review and meta-analysis de Aquino Moura, Karolinny Borinelli Behrens, Paula Marques Prates Pirolli, Rafaela Sauer, Aimee Melamed, Dayana Veronese, Francisco Veríssimo da Silva, André Luis Ferreira Azeredo Clin Kidney J CKD BACKGROUND: The aim of this study was to report the prevalence and mortality associated with anticoagulant-related nephropathy (ARN) through a systematic review of the literature. METHODS: Electronic searches were conducted in the Medline and EMBASE databases, and manual searches were performed in the reference lists of the identified studies. The studies were selected by two independent researchers, first by evaluating the titles and abstracts and then by reading the complete texts of the identified studies. Case series, cross-sectional studies, cohort studies and case–control studies reporting the prevalence and factors associated with ARN were selected. The methodological quality was assessed using the Newcastle–Ottawa scale. Meta-analyses of the prevalence of ARN and 5-year mortality using the random effects model were performed when possible. Heterogeneity was assessed using the I(2) statistic. RESULTS: Five studies were included. Prevalence of ARN ranged from 19% to 63% among the four included cohort studies. Meta-analysis of these resulted in high heterogeneity [I(2) 96%, summary effect 31%; 95% confidence interval (CI) 22–42%]. Subgroup meta-analysis yielded an ARN prevalence of 20% among studies that included patients with fewer comorbidities (I(2) 12%; 95% CI 19–22%). In a direct comparison, meta-analysis of the 5-year mortality rate between anticoagulated patients who had experienced ARN and anticoagulated patients without ARN, patients with ARN were 91% more likely to die (risk ratio = 1.91; 95% CI 1.22–3; I(2) 87%). Risk factors for ARN that were reported in the literature included initial excessive anticoagulation, chronic kidney disease, age, diabetes, hypertension, cardiovascular disease and heart failure. CONCLUSIONS: ARN studies are scarce and heterogeneous, and present significant methodological limitations. The high prevalence of ARN reported herein suggests that this entity is underdiagnosed in clinical practice. Mortality in patients with ARN seems to be high compared with patients without this condition in observational studies. Oxford University Press 2019-01-04 /pmc/articles/PMC6543958/ /pubmed/31198540 http://dx.doi.org/10.1093/ckj/sfy133 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | CKD de Aquino Moura, Karolinny Borinelli Behrens, Paula Marques Prates Pirolli, Rafaela Sauer, Aimee Melamed, Dayana Veronese, Francisco Veríssimo da Silva, André Luis Ferreira Azeredo Anticoagulant-related nephropathy: systematic review and meta-analysis |
title | Anticoagulant-related nephropathy: systematic review and meta-analysis |
title_full | Anticoagulant-related nephropathy: systematic review and meta-analysis |
title_fullStr | Anticoagulant-related nephropathy: systematic review and meta-analysis |
title_full_unstemmed | Anticoagulant-related nephropathy: systematic review and meta-analysis |
title_short | Anticoagulant-related nephropathy: systematic review and meta-analysis |
title_sort | anticoagulant-related nephropathy: systematic review and meta-analysis |
topic | CKD |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543958/ https://www.ncbi.nlm.nih.gov/pubmed/31198540 http://dx.doi.org/10.1093/ckj/sfy133 |
work_keys_str_mv | AT deaquinomourakarolinnyborinelli anticoagulantrelatednephropathysystematicreviewandmetaanalysis AT behrenspaulamarquesprates anticoagulantrelatednephropathysystematicreviewandmetaanalysis AT pirollirafaela anticoagulantrelatednephropathysystematicreviewandmetaanalysis AT saueraimee anticoagulantrelatednephropathysystematicreviewandmetaanalysis AT melameddayana anticoagulantrelatednephropathysystematicreviewandmetaanalysis AT veronesefranciscoverissimo anticoagulantrelatednephropathysystematicreviewandmetaanalysis AT dasilvaandreluisferreiraazeredo anticoagulantrelatednephropathysystematicreviewandmetaanalysis |